Want to see IN:INDRAMEDCO full AI Analyst Report?
Indraprastha Medical Corporation Limited (INDRAMEDCO) Stock Statistics & Valuation Metrics
Total Valuation
Indraprastha Medical Corporation Limited has a market cap or net worth of INR 27.97B. The enterprise value is INR 31.81B.
- Market Cap
- INR 27.97B
- Enterprise Value
- INR 31.81B
Share Statistics
Indraprastha Medical Corporation Limited has 91,673,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 91,673,000
- Owned by Insiders
- ―
- Owned by Institutions
- 0.58%
Financial Efficiency
Indraprastha Medical Corporation Limited’s return on equity (ROE) is 0.25 and return on invested capital (ROIC) is 20.19%.
- Return on Equity (ROE)
- 0.25
- Return on Assets (ROA)
- 0.19
- Return on Invested Capital (ROIC)
- 20.19%
- Return on Capital Employed (ROCE)
- 0.27
- Revenue Per Employee
- 4.94M
- Profits Per Employee
- 612.07K
- Employee Count
- 3,000
- Asset Turnover
- 1.50
- Inventory Turnover
- 124.30
Valuation Ratios
The current PE Ratio of Indraprastha Medical Corporation Limited is 14.87. Indraprastha Medical Corporation Limited’s PEG ratio is 1.23.
- PE Ratio
- 14.87
- PS Ratio
- 1.84
- PB Ratio
- 3.78
- Price to FCF
- 34.61
- Price to Operating Cash Flow
- 29.91
- PEG Ratio
- 1.23
Income Statement
In the last 12 months, Indraprastha Medical Corporation Limited had revenue of 14.83B and earned 1.84B in profits. Earnings per share was 20.03.
- Revenue
- 14.83B
- Gross Profit
- 5.06B
- Operating Income
- 2.23B
- Pretax Income
- 2.46B
- Net Income
- 1.84B
- EBITDA
- 2.96B
- Earnings Per Share (EPS)
- 20.03
Cash Flow
In the last 12 months, operating cash flow was 935.10M and capital expenditures -127.00M, giving a free cash flow of 808.10M billion.
- Operating Cash Flow
- 935.10M
- Free Cash Flow
- 808.10M
- Free Cash Flow per Share
- 8.82
Dividends & Yields
Indraprastha Medical Corporation Limited pays an annual dividend of INR 4.50, resulting in a dividend yield of 1.31%
- Dividend Per Share
- INR 4.50
- Dividend Yield
- 1.31%
- Payout Ratio
- 29.07%
- Free Cash Flow Yield
- 2.89%
- Earnings Yield
- 6.72%
Stock Price Statistics
- Beta
- 1.71
- 52-Week Price Change
- -48.35%
- 50-Day Moving Average
- 341.69
- 200-Day Moving Average
- 374.73
- Relative Strength Index (RSI)
- 34.52
- Average Volume (3m)
- 18.55K
Important Dates
Indraprastha Medical Corporation Limited upcoming earnings date is Feb 09, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 29, 2026
- Next Earnings Date
- Feb 09, 2027
- Ex-Dividend Date
- Sep 18, 2025
Financial Position
Indraprastha Medical Corporation Limited as a current ratio of 2.46, with Debt / Equity ratio of 4.98%
- Current Ratio
- 2.46
- Quick Ratio
- 2.41
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.11
- Interest Coverage Ratio
- 37.09
Taxes
In the past 12 months, Indraprastha Medical Corporation Limited has paid 624.00M in taxes.
- Income Tax
- 624.00M
- Effective Tax Rate
- 0.25
Enterprise Valuation
Indraprastha Medical Corporation Limited EV to EBITDA ratio is 9.47, with an EV/FCF ratio of 34.61.
- EV to Sales
- 1.84
- EV to EBITDA
- 9.47
- EV to Free Cash Flow
- 34.61
- EV to Operating Cash Flow
- 29.91
Balance Sheet
Indraprastha Medical Corporation Limited has INR 2.63B in cash and marketable securities with INR 0.00 in debt, giving a net cash position of INR 2.63B billion.
- Cash & Marketable Securities
- INR 2.63B
- Total Debt
- INR 0.00
- Net Cash
- INR 2.63B
- Net Cash Per Share
- INR 28.72
- Tangible Book Value Per Share
- INR 80.76
Margins
Gross margin is 33.90%, with operating margin of 14.99%, and net profit margin of 12.34%.
- Gross Margin
- 33.90%
- Operating Margin
- 14.99%
- Pretax Margin
- 16.57%
- Net Profit Margin
- 12.34%
- EBITDA Margin
- 19.39%
- EBIT Margin
- 16.42%
Analyst Forecast
The average price target for Indraprastha Medical Corporation Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 10.92%
- EPS Growth Forecast
- 12.12%
Scores
- Smart Score
- ―
- AI Score
- 71.4